Q1 2026 · 13F-HR
PFIZER INC (PFE)holdings as filed
Filed 2026-05-12 · accession 0000078003-26-000064
$238.8M
Reported value
18
Positions
2026-03-31
Period end
The Brief · PFIZER INC (PFE) · Q1 2026
AI · grounded in 13F
PFIZER INC (PFE) closed its position in AN2 THERAPEUTICS INC ANTX, reducing its holdings by $815,436. The fund established a new position in AGOMAB THERAPEUTICS NV AGMB valued at $813,750. Additionally, the fund trimmed its stake in Q32 BIO INC QTTB by 63.42% and reduced its holding in CELCUITY INC CELC by 15.38%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $57.7M | 24.1% | 4,780,401 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $49.8M | 20.9% | 22,032,040 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $34.9M | 14.6% | 3,457,815 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $31.3M | 13.1% | 295,652 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $16.8M | 7.05% | 2,838,913 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $11.9M | 5.00% | 1,875,000 | Common | SHARED |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $9.2M | 3.86% | 7,032,770 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $8.3M | 3.50% | 4,690,431 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $5.5M | 2.31% | 2,362,348 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $4.2M | 1.77% | 505,645 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $3.7M | 1.57% | 2,411,575 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $2.0M | 0.84% | 953,834 | Common | SOLE |
| 65343E207 | NXTC | NEXTCURE INC | $1.5M | 0.64% | 153,354 | Common | SOLE |
| 00860C102 | AGMB | AGOMAB THERAPEUTICS NV | $813,750 | 0.34% | 75,000 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $736,731 | 0.31% | 101,618 | Common | SOLE |
| 097702203 | BOLT | BOLT BIOTHERAPEUTICS INC | $137,116 | 0.06% | 31,305 | Common | SHARED |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $17,363 | 0.01% | 2,928 | Common | SOLE |
| 81727U105 | SENS1GBP | SENSEONICS HLDGS INC | $14,242 | 0.01% | 2,171 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.